SHH and medulloblastoma: In specific, mebendazole was also found to inhibit SHH signaling by hindering the formation of the primary cilium, and thus resulted in decreased proliferation of DAOY cells in vitro and extended the survival of SHH medulloblastoma orthotopic models [78,79].